Aller au contenu principal
Profil bibliographique

Yasutaka Murai

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

24Publications signalées
80Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Asthma and respiratory diseasesPeripheral Artery Disease ManagementMetabolism, Diabetes, and CancerAdipose Tissue and MetabolismEosinophilic Esophagitis

Les publications récentes

Accès ouvert 2023 supplementary-materials OpenAlex

Supplementary Material for: Effect of benralizumab on mucus plugs in severe eosinophilic asthma

Nobuyuki Sakai, Toshiyuki Koya, Yasutaka Murai, Fumito Tsubokawa et autres

Introduction: Mucus plugs are associated with airway obstruction in severe asthma and are involved in the formation of activated eosinophils. Benralizumab, an anti-interleukin-5 receptor antibody, markedly reduces not only peripheral blood eosinophils but also airway eosinophils; however, its effects on mucus plugs …

0 citations Figshare
Accès ouvert 2019 article OpenAlex

Analysis of haemodynamics and angiogenic response to ischaemia in the obese type 2 diabetic model Spontaneously Diabetic Torii Lepr fa (SDT fatty) rats

Yasutaka Murai, Tomohiko Sasase, Hironobu Tadaki, Shiro Heitaku et autres

Abstract Peripheral artery disease (PAD) is defined as peripheral blood flow impairment, especially in the legs, caused by atherosclerotic stenosis. The disease decreases quality of life because of intermittent claudication or necrosis of the leg. The hindlimb ischaemia model, in which ischaemia …

jp (code pays fourni par la source)

2 citations Clinical and Experimental Pharmacology and Physiology
Accès ouvert 2017 article OpenAlex

Investigation of Pharmacological Responses to an Anti-Diabetic Drug Pioglitazone in Female Spontaneously Diabetic Torii (SDT) Fatty Rats, A New Obese Type 2 Diabetic Rat

Yasutaka Murai, K Miyajima, Masami Shinohara, Takahisa Yamada et autres

Rigorous glycemic control is essential to prevent the development of diabetes and onset of diabetic complications. Peroxisome proliferator-activated receptor (PPAR) γ activator pioglitazone is an anti-diabetic drug that exhibits glucose-lowering effects by enhancing insulin sensitivity in peripheral tissues. However, increases in body …

0 citations Clinical Diabetes and Research
Accès ouvert 2017 article OpenAlex

Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model

Yasutaka Murai, Takeshi Ohta, Hironobu Tadaki, Katsuhiro Miyajima et autres

INTRODUCTION: The number of diabetic patients has recently been increasing worldwide, and numerous anti-diabetic drugs have been developed to induce good glycemic control. In particular, metformin, which exhibits glucose-lowering effects by suppressing gluconeogenesis in the liver, is widely used as a first …

jp, id (code pays fourni par la source)

19 citations Medical Archives
Accès ouvert 2014 article OpenAlex

The protein transportation pathway from Golgi to vacuoles via endosomes plays a role in enhancement of methylmercury toxicity

Gi‐Wook Hwang, Yasutaka Murai, Tsutomu Takahashi, Akira Naganuma

Methylmercury causes serious damage to the central nervous system, but the molecular mechanisms of methylmercury toxicity are only marginally understood. In this study, we used a gene-deletion mutant library of budding yeast to conduct genome-wide screening for gene knockouts affecting the sensitivity …

jp (code pays fourni par la source)

16 citations Scientific Reports

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.